ARCHIVES

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | December 31, 2004

Download PDF Visit The Full Archive

Related Articles

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

DCPC Board Approves Concepts For New Master Agreement, Recompetitions

October 9, 1987

NIH Human Connectome Project To Map Brain Connections

July 31, 2009